
|Videos|January 7, 2016
Dr. Arlene Sharpe on the Role of the PD-1 Pathway
Author(s)Arlene Sharpe, MD, PhD
Arlene Sharpe, MD, PhD, immunology faculty member, Harvard Medical School, discusses the biology of the PD-1 pathway.
Advertisement
Arlene Sharpe, MD, PhD, immunology faculty member, Harvard Medical School, discusses the biology of the PD-1 pathway.
The PD-1 pathway, which Sharpe’s lab helped define 15 years ago, inhibits immune responses, and protects against the development of autoimmunity. This prevents the activation and function of potentially pathogenic self reactive cells. The pathway also controls the resolution of inflammation, says Sharpe.
However, the most intriguing role of the PD-1 pathway is its ability to inhibit immune responses and allow tumors to avoid eradication, says Sharpe.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5


































